acetylcysteine has been researched along with Bladder Cancer in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, HJ; Choi, YH; Hong, SH; Hwang, EJ; Jeong, SJ; Jin, CY; Kim, GY; Kim, SO; Lee, H; Leem, SH; Park, C; Park, SH | 1 |
| Li, X; Zhao, B | 1 |
| Baek, JY; Choi, YH; Go, SI; Jeong, JW; Kim, GS; Kim, GY; Kim, HJ; Kwon, TK; Lee, JD; Lee, SJ; Lee, WS; Nagappan, A; Park, C; Ryu, CH; Shin, SC | 1 |
| Castiglioni, S; Cazzaniga, A; Maier, JA; Perrotta, C | 1 |
| Chavasiri, W; Gritsanapan, W; Muangman, V; Supabphol, A; Supabphol, R | 1 |
| Jiang, D; Liu, J; Liu, X; Sun, Z; Wang, H; Wang, J; Wang, W; Xiao, S; Ye, S | 1 |
| Du, H; Li, J; Li, XF; McGuigan, CF; Moe, B; Shen, S | 1 |
| Esuvaranathan, K; Mahendran, R; Pook, SH | 1 |
| Barrett, JC; French, JE; Honeycutt, HP; Jokinen, MP; Kari, FW; Martin, KR; Quinn, A | 1 |
| Li, G; Song, L; Tang, L; Zhang, Y | 1 |
| Hayakawa, M; Miyajima, A; Murai, M; Nakamura, K; Nakashima, J; Tachibana, M | 1 |
| Bicknell, R; Cranston, D; Fuggle, S; Fujiyama, C; Harris, AL; Jones, A | 1 |
| Davis, BB; Rice, JR; Spry, LA; Zenser, TV | 1 |
| Chester, JF; Gaissert, HA; Malt, RA; Ross, JS; Weitzman, SA | 1 |
14 other study(ies) available for acetylcysteine and Bladder Cancer
| Article | Year |
|---|---|
Cordycepin induces apoptosis in human bladder cancer T24 cells through ROS-dependent inhibition of the PI3K/Akt signaling pathway.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Chromones; Deoxyadenosines; Drug Evaluation, Preclinical; Humans; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Urinary Bladder Neoplasms | 2019 |
Altholactone induces reactive oxygen species-mediated apoptosis in bladder cancer T24 cells through mitochondrial dysfunction, MAPK-p38 activation and Akt suppression.
Topics: Acetylcysteine; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Furans; Gene Expression Regulation, Neoplastic; Humans; Mitochondria; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyrones; Reactive Oxygen Species; Urinary Bladder Neoplasms | 2014 |
Pachymic Acid Induces Apoptosis of EJ Bladder Cancer Cells by DR5 Up-Regulation, ROS Generation, Modulation of Bcl-2 and IAP Family Members.
Topics: Acetylcysteine; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Caspase 3; Caspases; Cytochromes c; DNA Fragmentation; Down-Regulation; Humans; Membrane Potential, Mitochondrial; Phospholipases A; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand; Triterpenes; Up-Regulation; Urinary Bladder Neoplasms | 2015 |
Silver nanoparticles-induced cytotoxicity requires ERK activation in human bladder carcinoma cells.
Topics: Acetylcysteine; Cell Line, Tumor; Cell Survival; Humans; MAP Kinase Signaling System; Metal Nanoparticles; Mitogen-Activated Protein Kinase 3; Reactive Oxygen Species; Silver; Urinary Bladder Neoplasms | 2015 |
N-acetylcysteine inhibits proliferation, adhesion, migration and invasion of human bladder cancer cells.
Topics: Acetylcysteine; Cell Adhesion; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Free Radical Scavengers; Humans; Neoplasm Invasiveness; Urinary Bladder Neoplasms | 2009 |
Beta-eleostearic acid induce apoptosis in T24 human bladder cancer cells through reactive oxygen species (ROS)-mediated pathway.
Topics: Acetylcysteine; Antioxidants; Apoptosis; Caspase 3; Caspase Inhibitors; Catalase; Cell Survival; Down-Regulation; Glutathione; Humans; Linolenic Acids; Polyethylene Glycols; PPAR gamma; Reactive Oxygen Species; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2012 |
Cytotoxicity and oxidative damage induced by halobenzoquinones to T24 bladder cancer cells.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Antioxidants; Benzoquinones; Cell Line, Tumor; Deoxyguanosine; Disinfectants; Drinking Water; Halogenation; Humans; Lipid Peroxidation; Malondialdehyde; Oxidative Stress; Protein Carbonylation; Urinary Bladder; Urinary Bladder Neoplasms | 2013 |
N-acetylcysteine augments the cellular redox changes and cytotoxic activity of internalized mycobacterium bovis in human bladder cancer cells.
Topics: Acetylcysteine; BCG Vaccine; Carcinoma, Transitional Cell; Cell Survival; Dexfenfluramine; Drug Synergism; Glutathione Reductase; Humans; Nitric Oxide; Reactive Oxygen Species; Superoxides; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2002 |
Tumor profile of novel p53 heterozygous Tg.AC (v-Ha-ras) bitransgenic mice treated with benzo(a)pyrene and fed dietary N-acetyl-L-cysteine (NAC).
Topics: Acetylcysteine; Animals; Anticarcinogenic Agents; Antioxidants; Benzo(a)pyrene; Carcinogens; Diet; Female; Gastric Mucosa; Genes, p53; Genes, ras; Hematologic Neoplasms; Male; Mice; Mice, Inbred Strains; Mice, Transgenic; Neoplasms; Papilloma; Pseudolymphoma; Sex Characteristics; Survival Analysis; Urinary Bladder Neoplasms | 2004 |
The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells.
Topics: Acetylcysteine; Apoptosis; Cell Cycle; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Isothiocyanates; Sulfoxides; Thiocyanates; Urinary Bladder Neoplasms | 2006 |
N-acetylcysteine modifies cis-dichlorodiammineplatinum-induced effects in bladder cancer cells.
Topics: Acetylcysteine; Antineoplastic Agents; Cisplatin; DNA Fragmentation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Free Radical Scavengers; Glutathione; Humans; In Situ Nick-End Labeling; Reactive Oxygen Species; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1999 |
Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion.
Topics: Acetylcysteine; Administration, Intravesical; Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Differentiation; Cell Division; Disease Models, Animal; Drug Screening Assays, Antitumor; Epithelium; Humans; Neoplasm Invasiveness; Phenotype; Rats; Rats, Sprague-Dawley; Suramin; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Urokinase-Type Plasminogen Activator | 2001 |
Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
Topics: Acetylcysteine; Animals; Carcinogens; FANFT; Glutathione; Male; Methimazole; Peroxidases; Propylthiouracil; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Thiazoles; Urinary Bladder Neoplasms | 1988 |
N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder cancer in mice: augmentation by sutures through the bladder wall.
Topics: Acetylcysteine; Animals; Carcinoma, Transitional Cell; Cocarcinogenesis; Cystitis; FANFT; Female; Mice; Sutures; Urinary Bladder Neoplasms | 1987 |